ArticleFrontiers in immunology2026
Case Report: Fibrin-associated large B-cell lymphoma developing within a cystic lesion of the adrenal gland: unexpected guest.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fibrin-associated large B-cell lymphoma (FA-LBCL) is recognized as a distinct entity in the 5th edition of the World Health Organization (WHO) classification of hematolymphoid tumors. It is a rare Epstein-Barr virus (EBV)-positive B-cell neoplasm that develops in areas of chronic fibrin deposition, associated with (pseudo)cystic cavities, long-standing hematomas, myxomas, or prosthetic devices. Cystic lymphangiomatous lesions of the adrenal gland are uncommon. Benign lymphovascular abnormalities are typically asymptomatic, but can be detected incidentally and removed to exclude other conditions. This report describes an exceptionally rare case involving a 42-year-old woman diagnosed incidentally with FA-LBCL arising within cystic lymphangiomatous lesions of the adrenal gland. We present a detailed account of the cytomorphological, immunohistochemical, and molecular characteristics of this FA-LBCL case and provide a concise overview of this emerging lymphoma subtype.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.